Application 220274
- Type
- ANDA
- Sponsor
- EXTROVIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SODIUM ACETATE | SODIUM ACETATE | SOLUTION;INTRAVENOUS | 100MEQ/50ML (2MEQ/ML) | No | No |
| 002 | SODIUM ACETATE | SODIUM ACETATE | SOLUTION;INTRAVENOUS | 200MEQ/100ML (2MEQ/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220274-001 | SODIUM ACETATE | SODIUM ACETATE | 100MEQ/50ML (2MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-17 | |
| A220274-002 | SODIUM ACETATE | SODIUM ACETATE | 200MEQ/100ML (2MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220274-001 | AP |
| A220274-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A220274-001 | SODIUM ACETATE | 100MEQ/50ML (2MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220274-002 | SODIUM ACETATE | 200MEQ/100ML (2MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-17 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220274-001 | SODIUM ACETATE | 100MEQ/50ML (2MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-17 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220274-002 | SODIUM ACETATE | 200MEQ/100ML (2MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A220274-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220274-002 | AP | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220274-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220274-002 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Acetate | SODIUM ACETATE | Amneal Pharmaceuticals Private Limited | 0c0b11da-d7fc-4b4c-b0ef-d97af8e88abf | 2026-08-21 | Warnings, Adverse reactions | Sodium Acetate SODIUM ACETATE |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | ce9a7469-c4ba-4f60-8f7a-47ef0974316e | 2026-03-26 | Warnings, Adverse reactions | Sodium Acetate SODIUM ACETATE |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | c91ede49-c7cc-47b7-0f93-e6841dd5916a | 2026-03-26 | Warnings, Adverse reactions | Sodium Acetate SODIUM ACETATE |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | abc41ed1-9512-4bea-9295-1a9ca134b6c2 | 2026-03-26 | Warnings, Adverse reactions | Sodium Acetate SODIUM ACETATE |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | c3be2468-45e8-4ecc-a30b-e966743a563f | 2026-03-26 | Warnings, Adverse reactions | Sodium Acetate SODIUM ACETATE |
| Sodium Acetate | SODIUM ACETATE | MILLA PHARMACEUTICALS INC. | 1ea1466d-a492-4056-e063-6394a90a80bf | 2026-01-07 | Warnings, Adverse reactions | Sodium Acetate SODIUM ACETATE |
| SODIUM ACETATE | SODIUM ACETATE | Amneal Pharmaceuticals Private Limited | 338105c0-c645-4b84-a125-4e1ead92b840 | 2025-08-11 | Warnings, Adverse reactions | SODIUM ACETATE SODIUM ACETATE |
| Sodium Acetate | SODIUM ACETATE | MILLA PHARMACEUTICALS INC. | 1ea04916-78e5-4651-e063-6394a90ac4be | 2025-01-16 | Warnings, Adverse reactions | Sodium Acetate SODIUM ACETATE |
| SODIUM ACETATE | SODIUM ACETATE | Fresenius Kabi USA, LLC | d7fabf08-d4e0-4bb5-8416-2e8ffe27c04b | 2024-10-11 | Warnings, Adverse reactions | SODIUM ACETATE SODIUM ACETATE |
| Sodium Acetate | SODIUM ACETATE | Hikma Pharmaceuticals USA Inc. | 8a338072-6f1e-460c-b9ec-59cef4f3f597 | 2024-05-08 | Warnings, Adverse reactions | Sodium Acetate SODIUM ACETATE |
| Sodium Acetate | SODIUM ACETATE | Hikma Pharmaceuticals USA Inc. | 7ee23a1c-bc99-4ff6-b2e7-d2aa42744553 | 2024-05-08 | Warnings, Adverse reactions | Sodium Acetate SODIUM ACETATE |